{"id":"https://openalex.org/W3105623749","doi":"https://doi.org/10.1016/j.ctarc.2020.100239","title":"Advances in the management of non-small cell lung cancer (NSCLC): A new practice changing data from asco 2020 annual meeting","display_name":"Advances in the management of non-small cell lung cancer (NSCLC): A new practice changing data from asco 2020 annual meeting","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3105623749","doi":"https://doi.org/10.1016/j.ctarc.2020.100239","mag":"3105623749","pmid":"https://pubmed.ncbi.nlm.nih.gov/33271494"},"language":"en","primary_location":{"id":"doi:10.1016/j.ctarc.2020.100239","doi":"https://doi.org/10.1016/j.ctarc.2020.100239","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctarc.2020.100239","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2468294220300745/pdf","source":{"id":"https://openalex.org/S4210186504","display_name":"Cancer Treatment and Research Communications","issn_l":"2468-2942","issn":["2468-2942"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment and Research Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2468294220300745/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086043239","display_name":"Mohammed Sqalli Houssa\u00efni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119819","display_name":"Universit\u00e9 Mohammed VI des Sciences et de la Sant\u00e9","ror":"https://ror.org/01tezat55","country_code":"MA","type":"education","lineage":["https://openalex.org/I4210119819"]},{"id":"https://openalex.org/I4210145847","display_name":"H\u00f4pital Universitaire International Cheikh Khalifa","ror":"https://ror.org/03g26ah87","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210145847"]}],"countries":["MA"],"is_corresponding":true,"raw_author_name":"Mohammed Sqalli Houssaini","raw_affiliation_strings":["Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco; Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco. Electronic address: msqallihoussaini@um6ss.ma","Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco","Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco; Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco. Electronic address: msqallihoussaini@um6ss.ma","institution_ids":["https://openalex.org/I4210119819","https://openalex.org/I4210145847"]},{"raw_affiliation_string":"Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210119819"]},{"raw_affiliation_string":"Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210145847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060629220","display_name":"Meriem Damou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119819","display_name":"Universit\u00e9 Mohammed VI des Sciences et de la Sant\u00e9","ror":"https://ror.org/01tezat55","country_code":"MA","type":"education","lineage":["https://openalex.org/I4210119819"]},{"id":"https://openalex.org/I4210145847","display_name":"H\u00f4pital Universitaire International Cheikh Khalifa","ror":"https://ror.org/03g26ah87","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210145847"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"Meriem Damou","raw_affiliation_strings":["Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco; Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco","Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco","Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco; Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210119819","https://openalex.org/I4210145847"]},{"raw_affiliation_string":"Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210119819"]},{"raw_affiliation_string":"Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210145847"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025778184","display_name":"Nabil Ismaili","orcid":"https://orcid.org/0000-0001-5786-5134","observed_orcids":["https://orcid.org/0000-0001-5786-5134"]},"institutions":[{"id":"https://openalex.org/I4210119819","display_name":"Universit\u00e9 Mohammed VI des Sciences et de la Sant\u00e9","ror":"https://ror.org/01tezat55","country_code":"MA","type":"education","lineage":["https://openalex.org/I4210119819"]},{"id":"https://openalex.org/I4210145847","display_name":"H\u00f4pital Universitaire International Cheikh Khalifa","ror":"https://ror.org/03g26ah87","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210145847"]}],"countries":["MA"],"is_corresponding":true,"raw_author_name":"Nabil Ismaili","raw_affiliation_strings":["Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco; Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco. Electronic address: nismaili@um6ss.ma","Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco","Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco; Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco. Electronic address: nismaili@um6ss.ma","institution_ids":["https://openalex.org/I4210119819","https://openalex.org/I4210145847"]},{"raw_affiliation_string":"Faculty of medicine, Mohammed VI university of health sciences, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210119819"]},{"raw_affiliation_string":"Medical oncology Department, Cheikh Khalifa University Hospital, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210145847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5025778184","https://openalex.org/A5086043239"],"corresponding_institution_ids":["https://openalex.org/I4210119819","https://openalex.org/I4210145847"],"apc_list":{"value":650,"currency":"USD","value_usd":650},"apc_paid":{"value":650,"currency":"USD","value_usd":650},"fwci":2.4456,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.91928573,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"25","issue":null,"first_page":"100239","last_page":"100239"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":1.0},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.8920000195503235},{"id":"https://openalex.org/keywords/locally-advanced-nsclc","display_name":"locally advanced non-small cell lung cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9290000200271606},{"id":"https://openalex.org/keywords/concurrent-chemoradiotherapy","display_name":"concurrent chemoradiotherapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.7689999938011169},{"id":"https://openalex.org/keywords/driver-mutations","display_name":"driver mutations","score":0.8209999799728394},{"id":"https://openalex.org/keywords/ret-fusion","display_name":"RET fusion","score":0.8510000109672546},{"id":"https://openalex.org/keywords/met-mutations","display_name":"MET mutations","score":0.9810000061988831},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6499999761581421},{"id":"https://openalex.org/keywords/tigit","display_name":"TIGIT","score":0.824999988079071},{"id":"https://openalex.org/keywords/tiragolumab","display_name":"tiragolumab","score":0.906000018119812},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.7938635349273682},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.768260657787323},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6708393096923828},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6217685341835022},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6133953332901001},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.52144855260849},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4840397238731384},{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.47437554597854614},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4526224136352539},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4293581247329712},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25860893726348877},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.2157788872718811},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.14169079065322876},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.13946077227592468},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049674","descriptor_name":"History, 21st Century","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ctarc.2020.100239","doi":"https://doi.org/10.1016/j.ctarc.2020.100239","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctarc.2020.100239","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2468294220300745/pdf","source":{"id":"https://openalex.org/S4210186504","display_name":"Cancer Treatment and Research Communications","issn_l":"2468-2942","issn":["2468-2942"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment and Research Communications","raw_type":"journal-article"},{"id":"pmid:33271494","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33271494","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment and research communications","raw_type":"Historical Article"},{"id":"pmh:oai:doaj.org/article:5efc46e05e944ca3bb888fb7343b2d66","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5efc46e05e944ca3bb888fb7343b2d66","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100239- (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ctarc.2020.100239","doi":"https://doi.org/10.1016/j.ctarc.2020.100239","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctarc.2020.100239","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2468294220300745/pdf","source":{"id":"https://openalex.org/S4210186504","display_name":"Cancer Treatment and Research Communications","issn_l":"2468-2942","issn":["2468-2942"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment and Research Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3105623749.pdf","grobid_xml":"https://content.openalex.org/works/W3105623749.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W133672860","https://openalex.org/W2054841768","https://openalex.org/W2272081149","https://openalex.org/W2924277568","https://openalex.org/W3028614809","https://openalex.org/W3028881097","https://openalex.org/W3029266488","https://openalex.org/W3029431941","https://openalex.org/W3029462827","https://openalex.org/W3029572589","https://openalex.org/W3030249953","https://openalex.org/W3030375299","https://openalex.org/W3030689340","https://openalex.org/W3030699384","https://openalex.org/W3030915148","https://openalex.org/W3031115858","https://openalex.org/W3031421614","https://openalex.org/W3031542967","https://openalex.org/W3032438306","https://openalex.org/W3032499029","https://openalex.org/W3032654870","https://openalex.org/W3033370892","https://openalex.org/W3093593316","https://openalex.org/W3179257167","https://openalex.org/W6605423069"],"related_works":["https://openalex.org/W3119456178","https://openalex.org/W4407578632","https://openalex.org/W3095500112","https://openalex.org/W4401354254","https://openalex.org/W4281808652","https://openalex.org/W4390346900","https://openalex.org/W3207647926","https://openalex.org/W4400694567","https://openalex.org/W4402049169","https://openalex.org/W4411216924"],"abstract_inverted_index":{"At":[0],"the":[1,4,32,36,49,71,75,106,157],"meeting":[2],"of":[3,7,51,77,108,137],"American":[5],"Society":[6],"Clinical":[8],"Oncology":[9],"(ASCO":[10],"2020),":[11],"held":[12],"this":[13],"year":[14],"virtually":[15],"on":[16],"May":[17],"29-31,":[18],"investigators":[19],"presented":[20],"important":[21],"practice":[22],"changing":[23],"findings":[24],"in":[25,54,111],"non-small":[26],"cell":[27],"lung":[28],"cancer":[29],"(NSCLC).":[30],"In":[31,67,89,122],"early-stage":[33],"resectable":[34],"NSCLC,":[35,70],"key":[37],"presentation":[38],"was":[39,105,140],"ADAURA":[40],"study.":[41],"This":[42],"phase":[43],"III":[44],"clinical":[45],"trial":[46],"showed":[47],"that":[48,164],"use":[50],"adjuvant":[52],"osimertinib":[53],"stage":[55],"IB-IIIA":[56],"NSCLC":[57,91,124],"patients":[58],"harboring":[59],"EGFR":[60],"mutations":[61],"had":[62],"a":[63],"clinically":[64],"meaningful":[65],"benefit.":[66],"locally":[68],"advanced":[69,123],"recent":[72,167],"studies":[73],"investigated":[74],"role":[76],"immune":[78,143],"checkpoint":[79,144],"inhibitors":[80],"(ICIs)":[81],"administred":[82],"early":[83],"with":[84,92,150],"or":[85,119],"before":[86],"concurrent":[87],"chemoradiotherapy.":[88],"advanced-stage":[90],"driver":[93],"mutations,":[94,127],"new":[95,129],"targets":[96],"and":[97,160],"drugs":[98],"were":[99,153],"explored.":[100],"The":[101],"major":[102],"step":[103],"forward":[104],"approval":[107],"personalized":[109],"treatment":[110],"very":[112],"uncommon":[113],"genomic":[114],"alterations,":[115],"as":[116],"RET":[117],"fusions":[118],"MET":[120],"mutations.":[121],"without":[125],"targetable":[126],"some":[128],"immunotherapy":[130],"combination":[131,139],"strategies":[132],"have":[133],"been":[134],"presented.":[135],"One":[136],"such":[138],"tiragolumab,":[141],"an":[142],"inhibitor":[145],"binding":[146],"to":[147,166],"TIGIT,":[148],"evaluated":[149],"atezolizumab.":[151],"There":[152],"also":[154],"data":[155],"from":[156],"Checkmate":[158,161],"227":[159],"9LA":[162],"trials":[163],"led":[165],"approvals.":[168]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":13}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2020-11-23T00:00:00"}